TrialMedical oncology (Northwood, London, England)2013

Phase II study of weekly PM00104 (ZALYPSIS(®)) in patients with pretreated advanced/metastatic endometrial or cervical cancer.

Lainie P Martin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.